A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2001
11/08/2001	WO2000041683A3 Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids
11/08/2001	US20010039441 Apparatuses and processes for whole-body hyperthermia
11/08/2001	US20010039414 Sustained release delivery systems for solutes
11/08/2001	US20010039302 Solvent-free and mastication-free production in an apparatus having a filling section and a compounding section; addition of the liquid components is made shortly after the polyisobutylene feed; for making patches or bandages
11/08/2001	US20010039298 Removable filter for slurry hydrocarbon synthesis process
11/08/2001	US20010039289 Antagonists; especially sodium salts
11/08/2001	US20010039260 Pulmonary insulin crystals
11/08/2001	US20010039258 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and to form a subcutaneously deliverable supramolecular complex, subcutaneously administering complex
11/08/2001	US20010039051 Utlizing the Varicella-Zoster virus protein's ability to enter and exit eukaryotic cells for drug or secreting agent delivery
11/08/2001	US20010039034 Method for labeling individual cells
11/08/2001	US20010038879 Solid delivery systems for aroma ingredients
11/08/2001	US20010038863 Modifying the effect of a first drug by adding a second drug; soporific agent and a stimulant for example
11/08/2001	US20010038862 Administering drug and sodium hydroxide, for example to a localized region of a human patient's body surface to enhance the flux of the drug through the localized region without causing damage thereto
11/08/2001	US20010038861 Administering the drug to a localized region of a human patient's body in combination with sodium hydroxide for example to enhance flux without irritating
11/08/2001	US20010038859 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/08/2001	US20010038858 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
11/08/2001	US20010038857 Method for application and maintenance of medication on body tissue
11/08/2001	US20010038856 Hydromorphone therapy
11/08/2001	US20010038855 Dosage form for administering prescribed dose
11/08/2001	US20010038854 Sustained-release preparation
11/08/2001	US20010038853 Suspending a pore-forming agent in an aqueous dispersion of a film-forming, water insoluble polymer to form a coating suspension having solid particles of pore former suspended therein, and coating a drug-containing solid core, drying
11/08/2001	US20010038852 Comprising active ingredient(s), a formulated mixture of polyvinyl acetate and polyvinylpyrrolidone, water soluble polymers or lipophilic additives, conventional excipients
11/08/2001	US20010038851 Therapeutic liposome composition and method of preparation
11/08/2001	US20010038850 Method for preventing crystal formation in a dispersion of a liquid in a matrix
11/08/2001	US20010038849 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
11/08/2001	US20010038846 Applying glycolic acid to the keloid scar long enough to promote atrophy of the damaged skin; nontoxic, inexpensive
11/08/2001	US20010038845 Parenterally administering large liposomes comprised of phospholipids free of sterol which pick-up cholesterol druing the treatment period; liposomes too large to penetrate fenestrations of endothelial lining hepatic sinusoids
11/08/2001	US20010038830 N,O-amidomalonate platinum complexes
11/08/2001	US20010038827 Inhalation comprising an effective amount of a vesicant and a pharmeceutically acceptable carrier, wherein the vesicant does not exhibit substantial toxicity while treating a patient for neoplasm
11/08/2001	US20010038826 Inhalation comprising an effective amount of a vesicant and a pharmeceutically acceptable carrier, wherein the vesicant does not exhibit substantial toxicity while treating a patient for neoplasm
11/08/2001	US20010038825 Method and compositions for enhancing pulmonary function and treating pulmonary disorders
11/08/2001	US20010038824 Aerothricins antifungal cyclic peptides
11/08/2001	US20010038823 Microparticles, process for their production, and their use in ultrasound diagnosis
11/08/2001	US20010037805 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
11/08/2001	EP1143938A3 Phinan
11/08/2001	DE10021165A1 System für die Freisetzung von Wirkstoffen System for the release of active ingredients
11/08/2001	CA2726789A1 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001	CA2433897A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir
11/08/2001	CA2408025A1 Method and facility for producing micromembrane capsules
11/08/2001	CA2407824A1 Pharmaceutical composition
11/08/2001	CA2407794A1 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds
11/08/2001	CA2407713A1 A core formulation
11/08/2001	CA2407700A1 Compositions and methods for inducing activation of dendritic cells
11/08/2001	CA2407614A1 Dried microorganism cell product by spray-drying
11/08/2001	CA2407337A1 A medicinal aerosol formulation
11/08/2001	CA2407292A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
11/08/2001	CA2407285A1 (+) naloxone and epinephrine combination therapy
11/08/2001	CA2407140A1 Directly compressed solid dosage particles
11/08/2001	CA2407134A1 Cancer therapy
11/08/2001	CA2407132A1 Use of n-heterocyclic substituted salicylates for inhibition of cellular uptake of cystine
11/08/2001	CA2407129A1 Medicinal formulation comprising pioglitazone
11/08/2001	CA2406823A1 Amphiphilic macrocyclic derivatives and their analogues
11/08/2001	CA2406516A1 Fiber optic probe placement guide
11/08/2001	CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	CA2378001A1 Preparation for nasal absorption of insulin
11/08/2001	CA2377880A1 Eutectic mixtures in cosmetic compositions
11/07/2001	EP1152026A1 Polysaccharide material for direct compression
11/07/2001	EP1152023A1 Inverse latex based on white mineral oils, squalane or hydrogenated polyisobutene, cosmetic compositions, dermocosmetics, dermopharmaceuticals or pharmaceutical compositions containing them
11/07/2001	EP1152022A1 Inverse latex based on white mineral oils, squalane, hydrogenated polyisobutene, isohexadecane or isododecane, cosmetic compositions, dermocosmetics, dermopharmaceuticals or pharmaceutical compositions containing them
11/07/2001	EP1151756A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus
11/07/2001	EP1151755A1 Pharmaceutical compositions comprising cyclosporin as active ingredient
11/07/2001	EP1151751A1 Cataplasms containing vitamin c or its derivative
11/07/2001	EP1151750A1 Medicinal compositions retarded in the discoloration of phenolic hydroxyl compounds
11/07/2001	EP1151749A1 Sheet-form adhesive preparation
11/07/2001	EP1151748A1 Continuous manufacturing procedure of microcapsules for extended release of water soluble peptides
11/07/2001	EP1151747A1 Modified release pharmaceutical formulations containing active principles having antibiotic activity
11/07/2001	EP1151746A1 Microcapsules for sustained release of drugs
11/07/2001	EP1151741A1 Microcapsules with an aqueous core containing at least an active water-soluble cosmetic or dermatologic ingredient and cosmetic or dermatologic compositions containing these microcapsules
11/07/2001	EP1151129A2 Methods of making compounds
11/07/2001	EP1151102A1 Glycosylated leptin compositions and related methods
11/07/2001	EP1151030A1 Novel membrane or matrix for controlling drug permeation
11/07/2001	EP1150988A1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
11/07/2001	EP1150981A1 Therapeutic nucleoside compound
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150935A1 Method and apparatus for shaping particles by ultrasonic cavitation
11/07/2001	EP1150918A2 Therapeutic calcium phosphate particles and methods of manufacture and use
11/07/2001	EP1150820A1 Injection molding method for neutral and acidic-group containing (meth)acrylate copolymers
11/07/2001	EP1150738A1 Implant
11/07/2001	EP1150717A1 Sustained release salts of pharmaceutically active peptides and their production
11/07/2001	EP1150716A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use
11/07/2001	EP1150715A1 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
11/07/2001	EP1150712A2 Human papilloma virus vaccine formulations
11/07/2001	EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
11/07/2001	EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
11/07/2001	EP1150703A1 Chaperonin 10 and beta-interferon therapy of multiple sclerosis
11/07/2001	EP1150686A1 Directly compressible matrix for controlled release of single daily doses of clarithromycin
11/07/2001	EP1150682A2 UBIQUINONE Qn FOR THE TREATMENT OF PAINS
11/07/2001	EP1150677A1 New pharmaceutical formulation
11/07/2001	EP1150675A1 A transdermal composition of an antivomiting agent and a preparation containing the same
11/07/2001	EP1150668A1 New utilization of alpha-hidroxy-propionic acid in medicine
11/07/2001	EP1150663A2 Method for producing film-type dosage forms
11/07/2001	EP1150662A1 Laminates containing an active substance for transdermal systems
11/07/2001	EP1150661A2 Topical sprays comprising a film forming composition
11/07/2001	EP1150660A1 Pharmaceutical effervescent formulation containing metamizol
11/07/2001	EP1150659A1 Inorganic shaped bodies and methods for their production and use
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP1150657A1 SPRAY CONTAINING UBIQUINONE Qn
11/07/2001	EP1150652A1 Skin lightening agents
11/07/2001	EP1150648A2 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates

1 ... 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 ... 2991